Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1370
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | AKTU | - |
dc.date.accessioned | 2025-10-03T05:54:12Z | - |
dc.date.available | 2025-10-03T05:54:12Z | - |
dc.date.issued | 2024-06 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1370 | - |
dc.language.iso | en_US | en_US |
dc.publisher | AKTU | en_US |
dc.subject | BP702T | en_US |
dc.subject | including Scale-Up, Technology Transfer, Packaging Technology, Quality Assurance, Quality Risk Management, Process Validation, GMP, Regulatory Affairs, New Drug Applications (NDAs), Good Laboratory Practices (GLP), and specific Indian regulations like those from the CDSCO | en_US |
dc.title | BP702T INDUSTRIAL PHARMACY II THEORY | en_US |
dc.type | Other | en_US |
Appears in Collections: | 2023-2024 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
BP702T INDUSTRIAL PHARMACY II THEORY.pdf | BP702T | 121.32 kB | Adobe PDF | Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.